ÂÜÀòÂÒÂ×

Christopher Hafner has a diverse and extensive work experience in the field of clinical and regulatory affairs. Christopher currently works as the Sr. Director of Clinical Affairs at SpyGlass Pharma, Inc. Christopher'sprevious roles include being the Sr. Director of Clinical and Regulatory Affairs at Equinox Ophthalmic, Inc., where they also served as the Director of Clinical and Regulatory Affairs. Prior to that, they were the Sr. Director of Clinical and Regulatory Affairs at Aurea Medical, LLC. Christopher has also held positions at ClarVista Medical, NuVasive Specialized Orthopedics, Ellipse Technologies, Inc., AqueSys, Inc., Baxter BioScience, NeuroSystec Corporation, and Boston Scientific Corporation.

Christopher Hafner earned a BA degree in Physiology and Psychology from the University of Minnesota between 1998 and 2003.